Jennet Harvey

5.4k total citations · 2 hit papers
52 papers, 4.3k citations indexed

About

Jennet Harvey is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Jennet Harvey has authored 52 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 23 papers in Cancer Research and 21 papers in Molecular Biology. Recurrent topics in Jennet Harvey's work include Breast Cancer Treatment Studies (15 papers), HER2/EGFR in Cancer Research (10 papers) and Breast Lesions and Carcinomas (7 papers). Jennet Harvey is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), HER2/EGFR in Cancer Research (10 papers) and Breast Lesions and Carcinomas (7 papers). Jennet Harvey collaborates with scholars based in Australia, United States and Cuba. Jennet Harvey's co-authors include Clark Gm, D. Craig Allred, Melora D. Berardo, D. Craig Allred, Gary M. Clark, C. Kent Osborne, Gregory F. Sterrett, Peter Robbins, Fabienne Grieu and Barry Iacopetta and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Journal of Urology.

In The Last Decade

Jennet Harvey

50 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

1998 1.8k citations Jennet Harvey et al. profile →
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer

1999 1.6k citations Jennet Harvey, Gary M. Clark et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Jennet Harvey

Since Specialization

Citations

This map shows the geographic impact of Jennet Harvey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennet Harvey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennet Harvey more than expected).

Fields of papers citing papers by Jennet Harvey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennet Harvey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennet Harvey. The network helps show where Jennet Harvey may publish in the future.

Co-authorship network of co-authors of Jennet Harvey

This figure shows the co-authorship network connecting the top 25 collaborators of Jennet Harvey. A scholar is included among the top collaborators of Jennet Harvey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennet Harvey. Jennet Harvey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Laboratory validation studies in Ki-67 digital image analysis of breast carcinoma: a pathway to routine quality assurance 2019 ·Pathology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Katie Meehan, (unknown), Cleo Robinson, (unknown), Jennet Harvey, (unknown), Benjamin F. Dessauvagie	6
2	Expression of proliferation genes in formalin-fixed paraffin-embedded (FFPE) tissue from breast carcinomas. Feasibility and relevance for a routine histopathology laboratory 2016 ·Journal of Clinical Pathology ·(unknown), Cleo Robinson, (unknown), Benjamin A. Wood, (unknown), Jennet Harvey, Benhur Amanuel	6
3	ERK/MAPK Regulation of the Androgen Responsiveness of Breast Cancer Cells 2008 ·Advances in experimental medicine and biology ·(unknown), (unknown), Melissa A. Greeve, Jennet Harvey, Jacqueline M. Bentel	8
4	Heterogeneous Staining for Mismatch Repair Proteins during Population-Based Prescreening for Hereditary Nonpolyposis Colorectal Cancer 2007 ·Journal of Molecular Diagnostics ·(unknown), Fabienne Grieu, M. J. Morris, Jennet Harvey, Colin J.R. Stewart, Lyn Schofield, Jack Goldblatt, Barry Iacopetta	71
5	Characterization of columnar cell lesions of the breast: immunophenotypic analysis of columnar alteration of lobules with prominent apical snouts and secretions 2006 ·Human Pathology ·Benjamin F. Dessauvagie, Wenying Zhao, (unknown), Jennet Harvey, Jacqueline M. Bentel	27
6	Infliximab and nephrotic syndrome 2005 ·Nephrology Dialysis Transplantation ·(unknown), Grant Luxton, Jennet Harvey	28
7	Atypical ductal hyperplasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis 2002 ·Pathology ·Jennet Harvey, Gregory F. Sterrett, Felicity Frost	42
8	Comparison of vascularity and angiogenesis in primary invasive mammary carcinomas and in their respective axillary lymph node metastases 2000 ·Clinical & Experimental Metastasis ·Michael J. Edel, Jennet Harvey, J. M. Papadimitriou	14
9	Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer breakdown → 1999 ·Journal of Clinical Oncology ·Jennet Harvey, Gary M. Clark, C. Kent Osborne, D. Craig Allred	1630
10	High density of small vessels expressing the tyrosine kinase receptor KDRin primary invasive breast carcinoma correlates with axillary lymph node metastases 1999 ·Angiogenesis ·Michael J. Edel, Jennet Harvey, Daniel J. Hicklin, Larry Witte, J. M. Papadimitriou	1
11	Assessment of vascularity in breast carcinoma by computer-assisted video analysis (CAVA) and its association with axillary lymph node status 1998 ·Breast Cancer Research and Treatment ·Michael J. Edel, Peter Robbins, J. M. Papadimitriou, M. D'Antuono, Jennet Harvey, (unknown), H.J.S. Dawkins	8
12	Predicting axillary lymph node metastases in breast carcinoma patients 1996 ·Breast Cancer Research and Treatment ·Peter Choong, (unknown), Hugh Dawkins, Gregory F. Sterrett, Peter Robbins, Jennet Harvey, J. M. Papadimitriou, Y. Attikiouzel	22
13	Hormone-Regulated Genes (pS2, PIP, FAS) in Breast Cancer and Nontumoral Mammary Tissue 1994 ·Pathobiology ·(unknown), Jennet Harvey, Peter Robbins, (unknown), (unknown)	8
14	BREAST CANCER IN WESTERN AUSTRALIA IN 1989: III. ACCURACY OF FNA CYTOLOGY IN DIAGNOSIS 1994 ·Australian and New Zealand Journal of Surgery ·(unknown), Jennet Harvey, Richard Parsons, Michael Byrne, (unknown), (unknown), Joanna Dewar, David Ingram, (unknown), F Cameron, (unknown)	5
15	What's New in Breast Cancer? 1993 ·Pathology - Research and Practice ·H.J.S. Dawkins, Peter Robbins, Karen Smith, Mohinder Sarna, Jennet Harvey, G. Sterrett, J. M. Papadimitriou	23
16	The undergraduate pathology course in the medical faculty of the university of western australia 1993 ·Pathology ·Jennet Harvey	1
17	Expression of the pS2 gene in breast cancer - a comparison of pS2 protein radioimmunoassay and immunohistochemistry 1993 ·Pathology ·Peter Robbins, (unknown), Gregory F. Sterrett, Jennet Harvey, (unknown), R. Hähnel	5
18	Expression of the pS2 gene in breast tissues assessed by pS2-mRNA analysis and pS2-protein radioimmunoassay 1992 ·Breast Cancer Research and Treatment ·(unknown), Peter Robbins, Jennet Harvey, Gregory F. Sterrett, R. Hähnel	5
19	Histological grading in breast cancer: interobserver agreement, and relation to other prognostic factors including ploidy 1992 ·Pathology ·Jennet Harvey, Nicholas de Klerk, Gregory F. Sterrett	34
20	Detection of estradiol-induced messenger RNA (pS2) in uninvolved breast tissue from mastectomies for breast cancer 1991 ·Breast Cancer Research and Treatment ·(unknown), (unknown), (unknown), Jennet Harvey, R. Hähnel	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact